Isogaine

Mepivacaine Hydrochloride, the active ingredient in Isogaine, is a local anesthetic (amide type) presented as a sterile injectable solution for intramuscular and subcutaneous use. It provides reversible nerve block to facilitate painless minor surgical, dental and diagnostic procedures in adult patients.

GNH USA supplies Isogaine as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company follows EU GMP standards and provides reliable global distribution for qualified healthcare institutions, ensuring timely delivery and regulatory support.

Mepivacaine Hydrochloride is used for local anesthesia in procedures involving the peripheral nervous system.

- Minor surgical procedures: provides localized numbness to enable painless incision and excision. - Dental procedures: allows pain‑free extractions, restorations and periodontal therapy. - Diagnostic or therapeutic regional anesthesia: facilitates targeted nerve blocks for various clinical interventions.

Mepivacaine Hydrochloride may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Injection site pain or bruising. - Transient tingling, numbness or metallic taste. - Mild dizziness or headache. - Temporary muscle weakness near the injection site.

Serious or Rare Side Effects: - Allergic reactions including anaphylaxis. - Cardiac arrhythmias or conduction disturbances. - Central nervous system toxicity such as seizures. - Severe hypotension or respiratory depression.

When using Mepivacaine Hydrochloride, clinicians should observe several safety measures.

- Allergy assessment: verify no known hypersensitivity to amide‑type local anesthetics. - Cardiac caution: avoid in patients with significant conduction disorders or recent myocardial infarction. - Intravascular injection: aspirate before injection to prevent systemic toxicity. - Dose monitoring: watch for signs of CNS toxicity when high cumulative doses are required. - Store at ambient temperature: keep in the original container, protect from light and moisture.

Mepivacaine Hydrochloride can interact with certain medications, influencing its safety profile.

Major Interactions (Avoid): - Class I antiarrhythmic agents (e.g., quinidine, procainamide): may increase cardiotoxicity. - Beta‑blockers: can exacerbate bradycardia when combined. - Monoamine oxidase inhibitors: risk of prolonged anesthetic effect.

Moderate Interactions (Monitor Closely): - Epinephrine‑containing solutions: may raise systemic absorption and toxicity. - CYP450 inhibitors (e.g., cimetidine): may alter drug metabolism and plasma levels.